Related Experiment Video
Updated: Jan 30, 2026

Vibrio cholerae: Model Organism to Study Bacterial Pathogenesis - Interview
Published on: May 28, 2007
Growth Inhibitory Effect of Lactocare on Vibrio cholerae
Mahsa Asadi1, Mohamad Reza Fazeli2, Azar Sabokbar1
1Dept of Microbiology, Islamic Azad University, Karaj branch, Karaj, Iran.
Insights
Lactocare, a commercial probiotic, demonstrated significant inhibitory effects against Vibrio cholerae. This suggests its potential in combating diarrheal diseases, particularly in vulnerable populations.
Area of Science:
- Microbiology
- Public Health
- Probiotics
Background:
- Acute microbial diarrheal diseases pose significant public health challenges, especially in developing nations.
- Children under five in Asia and Africa are disproportionately affected by waterborne microbial diseases.
- Limited financial resources and poor hygiene exacerbate the impact of diarrheal diseases.
Purpose of the Study:
- To investigate the comparative inhibitory effect of Lactocare, a commercial probiotic, on clinical samples and standard strains of Vibrio cholerae.
- To assess the antimicrobial activity of Lactocare against Vibrio cholerae.
Main Methods:
- Utilized 20 clinical samples and a standard strain (ATCC 14035) of Vibrio cholerae.
- Employed biochemical analysis and polymerase chain reaction (PCR) for sample confirmation.
- Applied the agar well diffusion method to determine the minimum inhibitory concentration (MIC) of Lactocare.
Main Results:
- Lactocare treatment at 30% concentration inhibited the standard strain of Vibrio cholerae.
- A 50% concentration of Lactocare led to a significant reduction in colony counts for clinical Vibrio cholerae samples, indicating a move towards the death phase.
- Higher concentrations of Lactocare are suggested to completely inhibit Vibrio cholerae growth.
Conclusions:
- Probiotics like Lactocare show promise in developing new pharmaceutical preparations and functional foods.
- These findings support the potential role of probiotics in promoting public health by controlling microbial diarrheal diseases.
Background And Objective:
Acute microbial diarrheal diseases are the major public health problems in the developing countries. People affected by diarrheal diseases have the lowest financial resources and poorest hygienic facilities. Children under five, primarily in Asian and African countries, are mostly the subjects affected by microbial diseases transmitted through water.The current study aimed at investigating the comparative inhibitory effect of Lactocare (commercial probiotic) on clinical samples and standard strains of Vibrio cholerae.
Methods:
A total of 20 clinical samples and a standard strain (ATCC 14035) were provided by Health Reference Laboratory and Biotechnology Institute, respective ly. In order to confirm the samples, biochemical analysis and the polymerase chain reaction (PCR) were performed on intergenic space. Afterward, agar well diffusion method was performed in order to measure the minimum inhibitory concentration to monitor the antimicrobial activity of Lactocare.
Results:
Colony count of V. cholerae for the standard strain in 30% and mean for clinical samples in 50% concentration of Lactocare treatment revealed that it would propel to death phase. Since the number of colonies decreased to 100, it was considered that higher concentrations of Lactocare would completely inhibit the growth of V. cholera.
Conclusion:
Probiotics are employed to develop new pharmaceutical preparations and functional foods in order to promote the public health.
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Population Growth
Meristems and Plant Growth
Exponential Growth
Relationship Growth
Primary and Secondary Growth in Roots and Shoots

